Xinmei Kang

机构：Sun Yat-sen University, Third Affiliated Hospital of Sun Yat-sen University · ORCID：0000-0002-3039-5221

发表论文 23 篇 · 总被引 378 次 · h-index 10

代表论文

• The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis (2022 · Molecular Therapy · 被引 76)
• Bone Marrow Mesenchymal Stem Cell‐Derived Dermcidin‐Containing Migrasomes enhance LC3‐Associated Phagocytosis of Pulmonary Macrophages and Protect against Post‐Stroke Pneumonia (2023 · Advanced Science · 被引 73)
• Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a (2022 · Nature Communications · 被引 64)
• Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression (2021 · Cell Death and Disease · 被引 36)
• Human Wharton's jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NF-κB signaling and glycolysis (2021 · Stem Cell Research & Therapy · 被引 25)
• STING Activation in Macrophages and Microglia Drives Poststroke Inflammation: Implications for Neuroinflammatory Mechanisms and Therapeutic Interventions (2024 · CNS Neuroscience & Therapeutics · 被引 17)